Literature DB >> 10924690

Nocistatin inhibits food intake in rats.

P K Olszewski1, T J Shaw, M K Grace, C J Billington, A S Levine.   

Abstract

Nocistatin, a product of the same precursor as nociceptin/orphanin FQ (N/OFQ), has been shown to antagonize effects of N/OFQ. N/OFQ stimulates feeding, most probably by inhibiting activation of neurons containing oxytocin (OT) and vasopressin (VP), peptides considered as satiety factors, and implicated in the development of conditioned taste aversion (CTA). The present study was designed to investigate whether intracerebroventricularly (ICV) injected nocistatin (a) affects deprivation- and N/OFQ-induced feeding, (b) causes CTA, and (c) induces activation of hypothalamic paraventricular (PVN) and supraoptic (SON) nuclei, as well as OT and VP neurons present in these regions. C-Fos immunohistochemistry was used as a marker of cellular activation. Nocistatin (1-3 nmol) significantly reduced food intake in deprived rats during the first and second hour post-injection. Doses of 1-3 nmol suppressed N/OFQ-induced feeding. Nocistatin at the highest (3 nmol) dose did not cause CTA. It also did not affect activation of the PVN or SON. In nocistatin-treated animals, the percentage of Fos-positive OT and VP neurons was similar to controls. We conclude that nocistatin antagonizes the influence of N/OFQ on feeding and suppresses deprivation-induced food consumption through mechanisms other than aversion. Nocistatin does not, however, activate the PVN or SON. It does not exert its effects via VP or OT neurons.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10924690     DOI: 10.1016/s0006-8993(00)02535-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  5 in total

Review 1.  Pharmacological approaches for the treatment of obesity.

Authors:  José-Antonio Fernández-López; Xavier Remesar; Màrius Foz; Marià Alemany
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Identification of NIPSNAP1 as a nocistatin-interacting protein involving pain transmission.

Authors:  Emiko Okuda-Ashitaka; Toshiaki Minami; Shingo Tsubouchi; Hiroshi Kiyonari; Akihiro Iwamatsu; Tetsuo Noda; Hiroshi Handa; Seiji Ito
Journal:  J Biol Chem       Date:  2012-02-06       Impact factor: 5.157

3.  Nocistatin and nociceptin modulate c-Fos expression in the mice thalamus.

Authors:  Jamil Ahsan Kazi
Journal:  Neurol Sci       Date:  2012-01-13       Impact factor: 3.307

4.  Nocistatin inhibits 5-hydroxytryptamine release in the mouse neocortex via presynaptic Gi/o protein linked pathways.

Authors:  M Fantin; C Fischetti; C Trapella; M Morari
Journal:  Br J Pharmacol       Date:  2007-07-09       Impact factor: 8.739

5.  Central injections of nocistatin or its C-terminal hexapeptide exert anxiogenic-like effect on behaviour of mice in the plus-maze test.

Authors:  Elaine C Gavioli; Giles A Rae; Girolamo Calo'; Remo Guerrini; Thereza C M De Lima
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.